EDWARD NOONAN: Open Payments
NPI 1376277939 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 36 payments from 13 companies in 2025. Trend: 2023 $547 · 2024 $368 · 2025 $903
Food & beverage: $903
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 4 | $169 |
| PFIZER INC. | 4 | $124 |
| Novartis Pharmaceuticals Corporation | 5 | $123 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $60 |
| BridgeBio Pharma, Inc. | 3 | $59 |
| Alnylam Pharmaceuticals Inc. | 2 | $43 |
| Amgen Inc. | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $35 |
Products named: LEQVIO, ELIQUIS, JARDIANCE, Attruby, WAINUA, ONPATTRO, Repatha, Adempas.
Industry payments across MA — which companies pay providers there.
